Revenue Estimates Analysis Of Quest Diagnostics Inc. (DGX)

Modesto Morganelli
Dicembre 3, 2017

The shares were sold at an average price of $108.16, for a total value of $5,833,393.28. Quest Diagnostics Inc now has $13.52B valuation. The stock increased 0.46% or $1.01 during the last trading session, reaching $218.6. APG Asset Management N.V. now owns 2,683,901 shares of the medical research company's stock worth $251,320,000 after purchasing an additional 1,635,700 shares during the period. EVINE Live Inc. (NASDAQ:EVLV) has risen 14.71% since December 2, 2016 and is uptrending. It has outperformed by 0.50% the S&P500.

Shares of Quest Diagnostics Inc (NYSE:DGX) traded up $0.75 during trading hours on Friday, hitting $99.21. Therefore 35% are positive. Quest Diagnostics Inc has a one year low of $87.34 and a one year high of $112.96. The rating was maintained by Morgan Stanley on Thursday, August 10 with "Underweight". The firm has "Sell" rating given on Friday, June 24 by Jyske Bank. The company was maintained on Wednesday, November 22 by Canaccord Genuity.

In terms of performance, we can pore into the stats for Quest Diagnostics Incorporated (NYSE:DGX). Finally, Zacks Investment Research lowered Quest Diagnostics from a "hold" rating to a "sell" rating in a research note on Friday, October 27th.

Investors sentiment decreased to 0.99 in 2017 Q2. Its down 0.05, from 1.04 in 2017Q1. Parallel Advisors LLC grew its holdings in shares of Quest Diagnostics by 0.9% during the second quarter. 78 funds opened positions while 158 raised stakes. 113.89 million shares or 2.51% less from 116.82 million shares in 2017Q1 were reported. Hillsdale Invest Mngmt accumulated 4,000 shares or 0.09% of the stock. Polaris Management Limited Liability Company holds 346,697 shares. It also upped Procter & Gamble Co (NYSE:PG) stake by 5,661 shares and now owns 131,450 shares. US Bancorp DE increased its position in Quest Diagnostics by 0.9% during the second quarter. Tarbox Family Office reported 0% stake. Acrospire Investment Management LLC now owns 1,600 shares of the medical research company's stock worth $178,000 after buying an additional 1,200 shares during the last quarter. Sei Invs invested in 164,666 shares or 0.07% of the stock. Amica Mutual Insur holds 12,993 shares or 0.13% of its portfolio. 10,722 are held by Nordea Investment Management Ab. Commercial Bank has invested 0.02% in Quest Diagnostics Incorporated (NYSE:DGX). About 456,941 shares traded.

Analysts await Quest Diagnostics Incorporated (NYSE:DGX) to report earnings on January, 25. It has outperformed by 22.34% the S&P500.

Quest Diagnostics Incorporated is a provider of diagnostic information services. The total amount of shares outstanding is 137.64 million, giving the company a market capitalization of about 13.55 billion. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. It has a 19.99 P/E ratio. This segment offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum, and Care360 brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, and phlebotomists in physician offices.

Among 21 analysts covering Constellation Brands (NYSE:STZ), 14 have Buy rating, 0 Sell and 7 Hold. Therefore 100% are positive. Constellation Brands had 68 analyst reports since August 27, 2015 according to SRatingsIntel. UBS maintained the stock with "Neutral" rating in Thursday, October 6 report. The stock has "Neutral" rating by Citigroup on Monday, October 9. The firm has "Buy" rating by RBC Capital Markets given on Tuesday, August 1. The firm has "Buy" rating given on Monday, December 7 by Argus Research. (NYSE:STZ) earned "Buy" rating by Cowen & Co on Monday, October 16. ValuEngine raised shares of Quest Diagnostics from a "hold" rating to a "buy" rating in a research note on Friday, September 1st. Mizuho set a $103.00 price objective on shares of Quest Diagnostics and gave the company a "buy" rating in a research note on Thursday, October 19th. It dropped, as 38 investors sold DGX shares while 200 reduced holdings. 108 funds opened positions while 221 raised stakes. Baldwin Brothers Ma reported 395 shares. Whittier Trust Communications Of Nevada owns 500 shares or 0.01% of their USA portfolio. Northcoast Asset Mgmt Ltd Liability Corp holds 175,096 shares or 2.25% of its portfolio. Maryland-based Profund Advsr Ltd Liability Com has invested 0.05% in Constellation Brands, Inc. Community Bancorporation Na stated it has 1,200 shares or 0.03% of all its holdings. Ny State Teachers Retirement invested in 234,342 shares. Bluefin Trading Ltd Com holds 71,719 shares. Following the transaction, the chief executive officer now owns 220,049 shares in the company, valued at $23,800,499.84. Company insiders own 1.75% of the company's stock. Sumitomo Mitsui Asset Company reported 13,760 shares. (NYSE:STZ) to report earnings on January, 4. The medical research company reported $1.39 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.35 by $0.04. DGX's profit will be $190.82M for 17.72 P/E if the $1.40 EPS becomes a reality. After $2.47 actual earnings per share reported by Constellation Brands, Inc. for the previous quarter, Wall Street now forecasts -23.89% negative EPS growth.

Receive News & Ratings for Quest Diagnostics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quest Diagnostics Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE